Octavius Pharma has developed DC granules of Empagliflozin for making Empagliflozin plain tablets. Product has been developed to ensure proper Dissolution profile throughout shelf life with optimal compressibility. The qualitative composition is in line with the innovator “Jardiance”, complies as per IH specification.
| Strength | 10 / 25 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | IH |
| API DMF | Available |
| CTD Dosssier | Available |
Empagliflozin: Empagliflozin is an anti-diabetic medication used in the management and treatment of type 2 diabetes mellitus. It is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields